NanoString Technologies Inc.

187 articles with NanoString Technologies Inc.

• NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares

  10/13/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previously announced underwritten public offering of 5,750,000 shares of its common stock at a price to the public of $40.00 per share pursuant to its existing shelf registration statement, for gross proceeds of $230.0 million. The number of shares issued at closing in

• OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users

  10/8/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System

• NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock

  10/7/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the pricing of an upsized underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $40.00 per share pursuant to its existing shelf registration statement, for gross proceeds of $200.0 million.

• NanoString Technologies Announces Commencement of Public Offering of Common Stock

  10/6/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that it intends to offer and sell, subject to market and other conditions, $150.0 million of shares of its common stock in an underwritten public offering pursuant to NanoString’s shelf registration statement. In connection with this offering, NanoString expects to grant the underwriters

• NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020

  10/6/2020

  - Third Quarter Product and Service Revenue of $30.1 Million vs. Guidance Range of $25 to $28 Million - - More than 25 New GeoMx DSP Orders Received in the Third Quarter - SEATTLE--( BUSINESS WIRE )-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today provided preliminary financial and operational highlights for the third quarter of 2020. Financial Highlig

• NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020

  10/5/2020

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will release third quarter 2020 operating results after the close of the market on Monday, November 9, 2020.

• NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites

  9/14/2020

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the establishment of the GeoMx Premier Access Sites, a global service network that will provide access to the GeoMx Cancer Transcriptome Atlas and future GeoMx commercial assays.

• NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference

  9/9/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the Morgan Stanley Global Healthcare Conference. Brad Gray, president and chief executive officer, is scheduled to present on Monday, Septem

• NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network

  9/9/2020

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the formation of the GeoMx Translational Leadership Network.

• NanoString to Present at the 2020 Baird Global Healthcare Conference

  9/3/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 Baird Global Healthcare Conference. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, September 9th, 2020 at 2:35pm ET. Interested parties can access the live webcast with accompa

• NanoString Technologies Releases Operating Results for Second Quarter of 2020

  8/10/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter of 2020.

• NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler

  8/6/2020

  Curated Menu of Off-the-Shelf RNAscope Probes Provide Seamless Molecularly-Guided Region of Interest Selection for Use With the New NGS-Enabled Cancer Transcriptome Atlas

• Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler

  8/6/2020

  Curated Menu of Off-the-Shelf RNAscope Probes Provide Molecularly-Guided Region of Interest Selection for Use with the New NGS-Enabled Cancer Transcriptome Atlas

• NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers

  8/3/2020

  Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers

• NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020

  7/8/2020

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will release second quarter 2020 financial results after the close of the market on Monday, August 10, 2020.

• NanoString Announces New Products to Advance COVID-19 Disease Research

  6/16/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the availability of new solutions to study the immune response in COVID-19 disease research.

• NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data

  5/20/2020

  NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a collaboration for the development of new analysis tools for data generated on NanoString’s nCounter® Analysis

• NanoString to Present at the UBS Global Healthcare Conference in May 20, 2020

  5/14/2020

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the company’s management is scheduled to present at the 2020 UBS Global Healthcare Conference.

• Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research

  5/12/2020

  Nature Biotechnology Publishes Comprehensive Description and Validation of the GeoMx Digital Spatial Profiler Using both nCounter & NGS Read Outs

• NanoString to Present at the Bank of America Health Care Conference

  5/11/2020

  NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the company’s management is scheduled to present at the 2020 Bank of America Securities Health Care Conference.